瀏覽天

21 2 月, 2022

European Commission Approves TEPMETKO® (tepotinib) for Patients with Advanced NSCLC with METex14 Skipping Alterations

首圖 DARMSTADT, Germany — (BUSINESS WIRE) — Merck, a leading science and technology company, today announced that the European Commission (EC) has approved once-daily oral TEPMETKO® (tepotinib)…


XPeng to be Added to The Hang Seng TECH Index as a Constituent Stock

首圖 GUANGZHOU, China–(BUSINESS WIRE)–XPeng Inc. (「XPeng」 or the 「Company,」 NYSE: XPEV, HKEX: 9868), a leading Chinese smart electric vehicle (「Smart EV」) company, is pleased to announce that it w…


Long-Term Follow-Up Data Reinforce Continued Overall Survival Benefit of BAVENCIO® (avelumab) First-Line Maintenance Treatment in Patients with Advanced Urothelial Carcinoma

首圖 DARMSTADT, Germany–(BUSINESS WIRE)–Merck, a leading science and technology company, today announced the results of an exploratory analysis from the Phase III JAVELIN Bladder 100 trial with 19…


什麼是3D模型(3D Modeling)? – 模範城市

首圖 3D 模型是一種將所有介面或物體透過多邊形、邊、面、頂點創造出三度空間虛擬呈現方式的過程，你可以在電影、動畫、電玩中看到眾多透過 3D 模型製成奇幻而充滿創意的生物與構造。 3D 模型可以用 3D 建模軟體產生，藝術家能夠利用 3D 建模軟體掃描實際物品並轉成數據點，建置或重塑多邊形介面來呈現某物件的虛擬 3D 型態。 3D 模型的應用方法 3D 模型廣泛用於許多…


Alofisel®▼ (darvadstrocel) Shows Clinical Remission Rate at Six-Months in the Real-World INSPIRE Study Interim Analysis Consistent with the Pivotal Clinical ADMIRE-CD Study1,2

首圖 OSAKA, Japan & CAMBRIDGE, Massachusetts–(BUSINESS WIRE)–Takeda (TSE:4502/NYSE:TAK) today announced the first six-month interim analysis results from INSPIRE, in which clinical r…